Pain News and Research

Latest Pain News and Research

Interferon linked with increased risk of depression in HCV patients

There's a high rate of depression among patients with hepatitis C, but a standard treatment for the disease includes a drug, interferon, that can cause depression.

2 May 2012

Pfizer receives FDA approval for Elelyso to treat Type 1 Gaucher disease

The U.S. Food and Drug Administration today approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease, a rare genetic disorder.

2 May 2012

Amoxicillin-clavulanate may improve small bowel function in children experiencing motility disturbances

The common antibiotic, amoxicillin-clavulanate, may improve small bowel function in children experiencing motility disturbances, according to a study appearing in the June print edition of the Journal of Pediatric Gastroenterology and Nutrition from Nationwide Children's Hospital.

30 Apr 2012

Astounding lack of public awareness about lung cancer

An astounding lack of public awareness about lung cancer has been revealed in a Cancer Research UK study, published today.

30 Apr 2012

Teva, Mylan settle patent infringement litigation for Nuvigil

Teva Pharmaceutical Industries Ltd., one of the world's largest producers of pharmaceuticals, announces that it has settled patent infringement litigation regarding U.S. Patent Number 7,132,570 (the "'570 patent") with respect to Mylan Inc.'s ANDA for Teva's wakefulness product NUVIGIL (armodafinil) tablets.

30 Apr 2012

Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis

Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced it has completed enrollment with 292 patients enrolled in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).

30 Apr 2012

Hispanic children less likely to receive medication for abdominal pain in ED

Black children are less likely than white children to receive medication for abdominal pain in the emergency department (ED) even when they report severe pain, according to a study to be presented Saturday, April 28, at the Pediatric Academic Societies (PAS) annual meeting in Boston.

30 Apr 2012

Pharmanest commences SHACT Phase I pharmacokinetic study

Karolinska Development: Pharmanest AB today announced that the first patient has been dosed in an open label pharmacokinetic study with its drug candidate SHACT, a product developed for pain relief in connection with intrauterine device (IUD) insertion.

30 Apr 2012

MCC researchers aim to improve cancer patient's quality of life and care

Researchers at Moffitt Cancer Center have placed new emphasis on gathering data on cancer patient quality of life during both treatment and survivorship. Their focus is on gathering and using that data to develop interventions to improve the quality of life for patients in treatment and for cancer survivors.

30 Apr 2012

Milner-Fenwick releases four new ‘Hospital Quality of Care’ videos

Hospitals are under fire. With heightened regulations and guidelines by the federal government and national health care organizations, the pressure to improve patient outcomes has never been greater. In response, the leading publisher of patient education videos, Milner-Fenwick, has released four new videos within its Hospital Quality of Care Series to help facilities comply with growing regulatory requirements. These videos address key hospital issues such as medication safety, infection control, fall prevention and discharge education.

30 Apr 2012

VIVUS receives FDA approval for Stendra to treat erectile dysfunction

The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.

30 Apr 2012

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STENDRA (avanafil) tablets for the treatment of erectile dysfunction (ED), marking the first new prescription agent approved in nearly a decade for the condition that afflicts as many as 30 million men in the U.S.

30 Apr 2012

Study reveals direct correlation between negative thinking about pain and poor sleep

Chronic pain sufferers who learn to dwell less on their ailments may sleep better and experience less day-to-day pain, according to results of research conducted on 214 people with chronic face and jaw pain.

27 Apr 2012

Research roundup: Practice guidelines may not stop defensive medicine; English language ability tied to hospital readmission rates

The Value of Clinical Practice Guidelines As Malpractice "Safe Harbors" -- Overspending on health care has frequently been attributed to doctors practicing defensive medicine -- ordering extra tests, for example -- so that they avoid malpractice lawsuits. The authors of this brief write that while some have said clinical guidelines "should give caregivers a liability 'safe harbor,' shielding them from any malpractice claim for failing to provide services not included in the guideline."

27 Apr 2012

New system assesses and records mobility of bedridden patients

Healthy people move an average of two to four times per hour in their sleep. The movements are triggered by pain that occurs when tissue has an insufficient blood supply. The sleeping person changes position involuntarily, relieves the pressure point and therefore prevents bedsores, which are known in professional jargon as "decubitus ulcers".

27 Apr 2012

State roundup: 'Green Houses' in Calif.; 'Accredtive Secret Sauce' gets scrutiny in Minn.

A new idea elbowed its way into the familiar pile of health care legislation in the Senate Committee on Health yesterday. A nursing home model -- the "Green House Project" -- bucks the cold, institutional feel of many long-term care facilities. ... The idea is to have a small facility laid out like a regular home, with living areas such as a dining room and kitchen, as well as a private room and bathroom for each patient.

27 Apr 2012

FDA approves Novartis’ Afinitor for treatment of renal angiomyolipomas and TSC

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.

27 Apr 2012

Viewpoints: Ma. health law trips up even bosses offering insurance; Traumatic brain disease may be complicating veterans' recoveries

Ronn Garry is an owner of Tropical Foods, the independent Roxbury market that has anchored Dudley Square for 36 years. He has 70 employees, 45 of them full time. The 2006 health law says he has to offer those full-time employees health insurance, cover at least 33 percent of their premiums, and get a quarter of them to take up his offer. Otherwise, he must pay a fine, called a Fair Share Contribution: $295 for every worker.

27 Apr 2012

GSK receives FDA approval for Votrient to treat advanced soft tissue sarcoma

The U.S. Food and Drug Administration today approved Votrient (pazopanib) to treat patients with advanced soft tissue sarcoma who have previously received chemotherapy. Soft tissue sarcoma is a cancer that begins in the muscle, fat, fibrous tissue, and other tissues.

27 Apr 2012

Positive top-line results from Shire’s Vyvanse Phase 2 study on binge eating disorder

Shire plc, the global specialty biopharmaceutical company, today announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) in adults with binge eating disorder.

27 Apr 2012

Pain News and Research

Latest Pain News and Research

Interferon linked with increased risk of depression in HCV patients

Pfizer receives FDA approval for Elelyso to treat Type 1 Gaucher disease

Amoxicillin-clavulanate may improve small bowel function in children experiencing motility disturbances

Astounding lack of public awareness about lung cancer

Teva, Mylan settle patent infringement litigation for Nuvigil

Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis

Hispanic children less likely to receive medication for abdominal pain in ED

Pharmanest commences SHACT Phase I pharmacokinetic study

MCC researchers aim to improve cancer patient's quality of life and care

Milner-Fenwick releases four new ‘Hospital Quality of Care’ videos

VIVUS receives FDA approval for Stendra to treat erectile dysfunction

FDA approves VIVUS’ STENDRA for treatment of erectile dysfunction

Study reveals direct correlation between negative thinking about pain and poor sleep

Research roundup: Practice guidelines may not stop defensive medicine; English language ability tied to hospital readmission rates

New system assesses and records mobility of bedridden patients

State roundup: 'Green Houses' in Calif.; 'Accredtive Secret Sauce' gets scrutiny in Minn.

FDA approves Novartis’ Afinitor for treatment of renal angiomyolipomas and TSC

Viewpoints: Ma. health law trips up even bosses offering insurance; Traumatic brain disease may be complicating veterans' recoveries

GSK receives FDA approval for Votrient to treat advanced soft tissue sarcoma

Positive top-line results from Shire’s Vyvanse Phase 2 study on binge eating disorder

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in